Restrictive and liberal red cell transfusion strategies in adult patients: Reconciling clinical data with best practice

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Mirski, Marek A ^a   Frank, Steven M ^a   Kor, Daryl J ^b   Vincent, Jean Louis ^c   Holmes, David R ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ADVERSE DRUG REACTION; ANEMIA; BLEEDING; BLOOD TRANSFUSION; BRAIN ISCHEMIA; CARDIOLOGY; CLINICAL TRIAL (TOPIC); ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FOLLOW UP; HEMORRHAGIC SHOCK; HUMAN; PRIORITY JOURNAL; REVIEW; SPINAL CORD ISCHEMIA; TRAUMATIC BRAIN INJURY; PRACTICE GUIDELINE; PROCEDURES; PROSPECTIVE STUDY; STANDARDS; STATISTICS;

ADULT; CLINICAL TRIALS AS TOPIC; ERYTHROCYTE TRANSFUSION; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; STATISTICS AS TOPIC;

EID: 84928708727     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0912-y     Document Type: Review

References (85)

1. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58.
2. Murphy DJ, Needham DM, Netzer G, Zeger SL, Colantuoni E, Ness P, et al. RBC transfusion practices among critically ill patients: has evidence changed practice? Crit Care Med. 2013;41:2344-53.
3. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17.
4. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39:1070-7.
5. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304:1559-67.
6. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, McKenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108:1108-11.
7. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453-62.
8. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381-91.
9. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11-21.
10. Carlson AP, Schermer CR, Lu SW. Retrospective evaluation of anemia and transfusion in traumatic brain injury. J Trauma. 2006;61:567-71.
11. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med. 2004;32:39-52.
12. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-507.
13. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249-54.
14. Brand A. Immunological aspects of blood transfusions. Blood Rev. 2000;14:130-44.
15. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg. 2000;87:1553-62.
16. Rachoin JS, Daher R, Schorr C, Milcarek B, Parrillo JE, Gerber DR. Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusion. Vox Sang. 2009;97:294-302.
17. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667-74.
18. Lebrón Gallardo M, Herrera Gutierrez ME, Seller Pérez G, Curiel Balsera E, Fernández Ortega JF, Quesada GG. Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl. 2004;10:1379-85.
19. LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, et al. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:796-803.
20. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555-62.
21. Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao SV, et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005;46:1490-5.
22. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101:1-7.
23. Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. JAMA. 2014;311:836-43.
24. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4, CD002042.
25. Napolitano LM, Kurek S, Luchette FA, Anderson GL, Bard MR, Bromberg W, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37:3124-67.
26. Practice guidelines for perioperative blood transfusion and adjuvant therapies. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198-208.
27. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160:445-64.
28. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50:753-65.
29. Doyle BJ, Rihal CS, Gastineau DA, Holmes Jr DR. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53:2019-27.
30. Tsai HI, Chou AH, Yang MW. Perioperative transfusion-related acute lung injury: a retrospective analysis. Acta Anaesthesiol Taiwan. 2012;50:96-100.
31. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119:1757-67.
32. Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet. 2013;382:984-94.
33. McIntyre L, Hebert PC, Wells G, Fergusson D, Marshall J, Yetisir E, et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma. 2004;57:563-8.
34. Hébert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227-34.
35. Park DW, Chun BC, Kwon SS, Yoon YK, Choi WS, Sohn JW, et al. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis. Crit Care Med. 2012;40:3140-5.
36. Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P. Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology. 2008;108:31-9.
37. Pidcoke HF, Aden JK, Mora AG, Borgman MA, Spinella PC, Dubick MA, et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg. 2012;73:S445-52.
38. Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, et al. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. J Trauma Acute Care Surg. 2012;73:358-64.
39. Halmin M, Boström F, Brattström O, Lundahl J, Wikman A, Östlund A, et al. Effect of plasma-to-RBC ratios in trauma patients: a cohort study with time-dependent data. Crit Care Med. 2013;41:1905-14.
40. Sambasivan CN, Kunio NR, Nair PV, Zink KA, Michalek JE, Holcomb JB, et al. High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma. 2011;71:S329-36.
41. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PGR, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg. 2010;210:957-65.
42. Edens JW, Chung KK, Pamplin JC, Allan PF, Jones JA, King BT, et al. Predictors of early acute lung injury at a combat support hospital: a prospective observational study. J Trauma. 2010;69:S81-6.
43. Yang JC, Sun Y, Xu CX, Dang QL, Li L, Xu YG, et al. Correlation between red blood cell transfusion volume and mortality in patients with massive blood transfusion: a large multicenter retrospective study. Exp Ther Med. 2015;9:137-42.
44. Balducci L. Anemia, fatigue and aging. Transfus Clin Biol. 2010;17:375-81.
45. Terekeci HM, Kucukardali Y, Onem Y, Erikci AA, Kucukardali B, Sahan B, et al. Relationship between anaemia and cognitive functions in elderly people. Eur J Intern Med. 2010;21:87-90.
46. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community dwelling disabled older women? J Am Ger Soc. 2004;52:1811-6.
47. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719-24.
48. Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37:173-8.
49. Hollman JH, Beckman BA, Brandt RA, Merriwether EN, Williams RT, Nordrum JT. Minimum detectable change in gait velocity during acute rehabilitation following hip fracture. J Geriatr Phys Ther. 2008;31:53-6.
50. Latham NK, Mehta V, Nguyen AM, Jette AM, Olarsch S, Papanicolaou D, et al. Performance-based or self-report measures of physical function: which should be used in clinical trials of hip fracture patients? Arch Phys Med Rehabil. 2008;89:2146-55.
51. Neal MD, Hoffman MK, Cuschieri J, Minei JP, Maier RV, Harbrecht BG, et al. Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: when a little goes a long way. J Trauma Acute Care Surg. 2012;72:892-8.
52. Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients, European Society of Intensive Care Medicine. Intensive Care Med. 2012;38:368-83.
53. Cohen MJ. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am. 2012;92:877-91.
54. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165:964-71.
55. Diedler J, Sykora M, Hahn P, Heerlein K, Schölzke MN, Kellert L, et al. Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage. Crit Care. 2010;14:R63.
56. Oddo M, Milby A, Chen I, Frangos S, MacMurtrie E, Maloney-Wilensky E, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:1275-81.
57. Levy PS, Kim SJ, Eckel PK, Chavez R, Ismail EF, Gould SA, et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol. 1993;265:H340-9.
58. Chaplin Jr H, Beutler E, Collins JA, Giblett ER, Polesky HF. Current status of red-cell preservation and availability in relation to the developing national blood policy. N Engl J Med. 1974;291:68-74.
59. Marik P, Sibbald W. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 1993;269:3024-9.
60. Weiskopf RB, Feiner J, Hopf H, Lieberman J, Finlay HE, Quah C, et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology. 2006;104:911-20.
61. Walsh T, McArdle F, McLellan SA, Maciver C, Maginnis M, Prescott RJ, et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med. 2004;32:364-71.
62. Roberson RS, Lockhart E, Shapiro NI, Bandarenko N, McMahon TJ, Massey MJ, et al. Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers. Transfusion. 2012;52:2459-64.
63. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042-9.
64. Rousseau M, Yan RT, Tan M, Lefkowitz CJ, Casanova A, Fitchett D, et al. Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring. Am J Cardiol. 2010;106:1417-22.
65. Zarroy O, Hoeks SE, Valentijn T, Leendertse-Verloop K, Van Klei WA, Jan Stolker R, et al. Postoperative hemoglobin levels and its association with myocardial ischemia in non-cardiac surgical patients. Minerva Anestesiol. 2014;80:204-10.
66. Gutierrez A, Tsai TT, Stanislawski MA, Vidovich M, Bryson CL, Bhatt DL, et al. Adoption of transradial percutaneous coronary intervention and outcomes according to center radial volume in the Veterans Affairs Healthcare System: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program. Circ Cardiovasc Interv. 2013;6:336-46.
67. Ergelen M, Uyarel H, Altay S, Ayhan E, Isik T, Bacaksiz A, et al. Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction. Coron Artery Dis. 2012;23:517-22.
68. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4:654-64.
69. Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303:2156-64.
70. Prada-Delgado Ó, Estévez-Loureiro R, Calviño-Santos R, Barge-Caballero E, Salgado-Fernández J, Piñón-Esteban P, et al. Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am Heart J. 2011;161:1207-13.
71. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schömig A, et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51:690-7.
72. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019-25.
73. Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol. 2003;92:930-5.
74. Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008;1:202-9.
75. Correia LC, Souza AC, Sabino M, Brito M, Maraux M, Garcia G, et al. Hemoglobin level adds prognostic value to the global registry of acute coronary events score in non-ST elevation acute coronary syndromes. Cardiology. 2012;121:213-9.
76. Ennezat PV, Maréchaux S, Pinçon C, Finzi J, Barrailler S, Bouabdallaoui N, et al. Anaemia to predict outcome in patients with acute coronary syndromes. Arch Cardiovasc Dis. 2013;106:357-65.
77. Ang DS, Kao MP, Noman A, Lang CC, Struthers AD. The prognostic significance of early and late anaemia in acute coronary syndrome. QJM. 2012;105:445-54.
78. Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J. 2009;30:1331-9.
79. Maréchaux S, Barrailler S, Pinçon C, Decourcelle V, Guidez T, Braun S, et al. Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels. 2012;27:119-27.
80. Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 2013;S0140-6736:61720-1.
81. Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA. GRACE and GRACE2 Investigators. The Global Registry of Acute Coronary Events, 1999 to 2009 - GRACE. Heart. 2010;96:1095-101.
82. Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007;116:2793-801.
83. Wendler O, Walther T, Nataf P, Rubino P, Schroefel H, Thielmann M, et al. Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg. 2010;38:119-27.
84. Josephson CD, Glynn SA, Kleinman SH, Blajchman MA. State-of-the Science Symposium Transfusion Medicine Committee. A multidisciplinary 'think tank': the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. Transfusion. 2011;51:828-41.
85. Deans KJ, Minneci PC, Klein HG, Natanson C. The relevance of practice misalignments to trials in transfusion medicine. Vox Sang. 2010;99:16-23.